Skip to main content
. 2019 Jan 28;2019(1):CD008940. doi: 10.1002/14651858.CD008940.pub3

Comparison 2. Selective serotonin‐reuptake inhibitor (SSRI) antidepressant versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Participants abstinent at end of treatment 2 128 Risk Ratio (M‐H, Random, 95% CI) 1.73 [0.61, 4.89]
2 Participants experiencing adverse effects 1 76 Risk Ratio (M‐H, Random, 95% CI) 0.76 [0.57, 1.02]
3 Participants withdrawn due to adverse effects 1 76 Risk Ratio (M‐H, Random, 95% CI) 1.71 [0.16, 18.04]
4 Completion of scheduled treatment 3 198 Risk Ratio (M‐H, Random, 95% CI) 0.79 [0.49, 1.27]